DK2192896T3 - Carbonylamino derivater, der er anvendelige til behandling af inflammatorisk tarmsygdom - Google Patents

Carbonylamino derivater, der er anvendelige til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK2192896T3
DK2192896T3 DK08787357.6T DK08787357T DK2192896T3 DK 2192896 T3 DK2192896 T3 DK 2192896T3 DK 08787357 T DK08787357 T DK 08787357T DK 2192896 T3 DK2192896 T3 DK 2192896T3
Authority
DK
Denmark
Prior art keywords
treatment
inflammatory bowel
bowel disease
derivatives useful
carbonylamino derivatives
Prior art date
Application number
DK08787357.6T
Other languages
English (en)
Inventor
Lars Siim Madsen
Palle Christophersen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK2192896T3 publication Critical patent/DK2192896T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK08787357.6T 2007-08-24 2008-08-21 Carbonylamino derivater, der er anvendelige til behandling af inflammatorisk tarmsygdom DK2192896T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95781107P 2007-08-24 2007-08-24
DKPA200701211 2007-08-24
PCT/EP2008/060910 WO2009027292A1 (en) 2007-08-24 2008-08-21 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders

Publications (1)

Publication Number Publication Date
DK2192896T3 true DK2192896T3 (da) 2011-04-04

Family

ID=39870538

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08787357.6T DK2192896T3 (da) 2007-08-24 2008-08-21 Carbonylamino derivater, der er anvendelige til behandling af inflammatorisk tarmsygdom

Country Status (11)

Country Link
US (1) US8455549B2 (da)
EP (2) EP2322164A3 (da)
JP (1) JP2010536827A (da)
AT (1) ATE494891T1 (da)
DE (1) DE602008004563D1 (da)
DK (1) DK2192896T3 (da)
ES (1) ES2358564T3 (da)
HR (1) HRP20110189T1 (da)
PL (1) PL2192896T3 (da)
PT (1) PT2192896E (da)
WO (1) WO2009027292A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2742610A1 (en) 2008-11-10 2010-05-14 Jun Li Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
US10179115B2 (en) 2015-02-20 2019-01-15 The Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
WO2018081018A1 (en) * 2016-10-25 2018-05-03 Paracelsus Neuroscience Llc Use of senicapoc for treatment of neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889038A (en) 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
NZ332103A (en) 1996-03-20 2000-08-25 Nuchem Pharmaceuticals Inc Triphenyl methane compounds or analogues thereof where one or more of the phenyl groups is substituted and the tertiary carbon atom is replaced for sickle cell disease,
US6288122B1 (en) 1999-02-23 2001-09-11 Icagen, Inc. Gardos channel antagonists
US6548522B1 (en) * 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US6803375B1 (en) 2000-01-06 2004-10-12 The Regents Of The University Of California Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
AU2003201273A1 (en) 2002-01-04 2003-07-30 Poseidon Pharmaceuticals A/S Potassium channel modulators
US7129618B2 (en) * 2003-03-31 2006-10-31 Canon Kabushiki Kaisha Control apparatus capable of low-speed driving of vibration type driving apparatus, actuating apparatus using the control apparatus, control method capable of low-speed driving of vibration type driving apparatus, and storage medium storing program including program codes capable of realizing the control method
GB0414272D0 (en) 2004-06-25 2004-07-28 Cellpep Sa OsK1 derivatives
KR20080086511A (ko) * 2005-12-20 2008-09-25 이카겐, 인코포레이티드 트리아릴 메탄 화합물을 이용한 치료 방법

Also Published As

Publication number Publication date
DE602008004563D1 (de) 2011-02-24
EP2322164A3 (en) 2011-12-07
ATE494891T1 (de) 2011-01-15
HRP20110189T1 (hr) 2011-04-30
EP2322164A2 (en) 2011-05-18
JP2010536827A (ja) 2010-12-02
WO2009027292A1 (en) 2009-03-05
PT2192896E (pt) 2011-04-04
PL2192896T3 (pl) 2011-06-30
US8455549B2 (en) 2013-06-04
US20110124735A1 (en) 2011-05-26
EP2192896B1 (en) 2011-01-12
ES2358564T3 (es) 2011-05-11
EP2192896A1 (en) 2010-06-09

Similar Documents

Publication Publication Date Title
LTPA2018509I1 (lt) Piperazinu pakeisti benzotiofenai, skirti psichikos sutrikimų gydymui
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK2300443T3 (da) Triazolderivater, der er anvendelige til behandling af sygdomme
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
MY153971A (en) Sulfonamides as trpm8 modulators
DK2019683T4 (da) Indgivelse af vækstfaktorer til behandling af CNS-lidelser
BRPI0918527A2 (pt) compostos para o tratamento de disturbios do cns
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
CO6170359A2 (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematologicas
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
CR20130308A (es) Compuestos y su uso como inhibidores de bace
BRPI0812755A2 (pt) Compostos de derivados de fenil alquinila para tratar doenças, e desordens oftálmicas
BRPI0906618A2 (pt) Derivados de diazepinorimidona de arilamida substituídos para o tratamento de doenças neu-rodegenerativas causadas por atividade anorma de gsk3-beta
ATE502012T1 (de) 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivat
DK2041093T3 (da) Til behandling af GPR38-receptor medierede sygdomme anvendelige piperazinylderivativer
BRPI0911577A8 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
MA32505B1 (fr) 5-alcynyl-pyrimidines
DK3689346T3 (da) 3,6-disubstitueret xanthyliumsalte til behandling af tauopati
BRPI0821102A2 (pt) Preparação de derivados de di-hidropirrol como intermediários
DK2148667T3 (da) Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme
DK2124884T3 (da) Sammensætninger, der omfatter galdesyresekvestreringsmidler til behandling af øsofageale forstyrrelser
BRPI0815059A2 (pt) Derivado de 1,3-di-hidroisoindol
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
SE0800742L (sv) Vikttäcke